Insights

Growth and Acquisition Cenexi has experienced recent strategic growth, highlighted by its acquisition by Fosun Pharma in 2022 for up to 130 million dollars, signaling strong investor confidence and potential for expansion into new markets and therapeutic areas.

Innovation Focus The company collaborates on innovative projects such as developing needle-free autoinjectors and expanding sterile product expertise, indicating opportunities to supply advanced manufacturing solutions and supportive technologies.

Market Positioning With a robust portfolio in cytotoxic and hormonal products, Cenexi is well-positioned in high-demand pharmaceutical niches, creating opportunities for suppliers with specialized equipment, raw materials, or regulatory services tailored to sterile and cytotoxic manufacturing.

International Expansion Operating across multiple European sites and with a recent acquisition by an international player, Cenexi presents an entry point for global partners seeking to expand their manufacturing footprint within Europe.

Market Trends Alignment The company's focus on sterile pharmaceuticals and innovative delivery systems aligns with current market trends emphasizing safety, reducing needle use, and enhanced patient compliance, offering opportunities to introduce complementary technologies or materials.

PHINEX - CENEXI Tech Stack

PHINEX - CENEXI uses 8 technology products and services including SAS, Mailjet, Font Awesome, and more. Explore PHINEX - CENEXI's tech stack below.

  • SAS
    Business Intelligence
  • Mailjet
    Email
  • Font Awesome
    Font Scripts
  • Cisco
    Network Hardware
  • Bootstrap
    UI Frameworks
  • Minitab
    Visualisation Software
  • Google Analytics
    Web Analytics
  • WPML
    Web Platform Extensions

PHINEX - CENEXI's Email Address Formats

PHINEX - CENEXI uses at least 1 format(s):
PHINEX - CENEXI Email FormatsExamplePercentage
First.Last@cenexi.comJohn.Doe@cenexi.com
95%
First.MiddleLast@cenexi.comJohn.MichaelDoe@cenexi.com
2%
First@cenexi.comJohn@cenexi.com
2%
FLast@cenexi.comJDoe@cenexi.com
1%

Frequently Asked Questions

What is PHINEX - CENEXI's phone number?

Minus sign iconPlus sign icon
You can contact PHINEX - CENEXI's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PHINEX - CENEXI's official website and social media links?

Minus sign iconPlus sign icon
PHINEX - CENEXI's official website is cenexi.com and has social profiles on LinkedIn.

What is PHINEX - CENEXI's SIC code NAICS code?

Minus sign iconPlus sign icon
PHINEX - CENEXI's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PHINEX - CENEXI have currently?

Minus sign iconPlus sign icon
As of December 2025, PHINEX - CENEXI has approximately 1K employees across 4 continents, including EuropeNorth AmericaAfrica. Key team members include Ceo: A. K.Cfo Services – Cenexi Group: F. M.Cfo Services - Cenexi Group: F. M.. Explore PHINEX - CENEXI's employee directory with LeadIQ.

What industry does PHINEX - CENEXI belong to?

Minus sign iconPlus sign icon
PHINEX - CENEXI operates in the Pharmaceutical Manufacturing industry.

What technology does PHINEX - CENEXI use?

Minus sign iconPlus sign icon
PHINEX - CENEXI's tech stack includes SASMailjetFont AwesomeCiscoBootstrapMinitabGoogle AnalyticsWPML.

What is PHINEX - CENEXI's email format?

Minus sign iconPlus sign icon
PHINEX - CENEXI's email format typically follows the pattern of First.Last@cenexi.com. Find more PHINEX - CENEXI email formats with LeadIQ.

When was PHINEX - CENEXI founded?

Minus sign iconPlus sign icon
PHINEX - CENEXI was founded in 2004.

PHINEX - CENEXI

Pharmaceutical ManufacturingÎle-de-france, France1001-5000 Employees

Cenexi, a French Contract Development and Manufacturing Organization with its 1,500 employees and 200 million € of turnover, is experiencing a steady growth with its four manufacturing sites (Fontenay-sous-Bois, Osny and Hérouville-Saint-Clair in France, Braine-l'Alleud in Belgium) and one development center for New Product Introduction.
Created in 2004, the Cenexi Group is positioned on the very active international market for medicinal products with a major therapeutic indication, drawing on its spirit of innovation and its extensive expertise, both in manufacturing and in product development
The arrival of the new top management team induces a new dynamic into the company, in particular by strengthening its sterile expertise which represents 70% of our core business.
Cenexi has the production capacities of many dosage forms with strong expertise in cytotoxic products (including hormonal).

Section iconCompany Overview

Phone number
Website
cenexi.com
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2004
Employees
1001-5000

Section iconFunding & Financials

  • $10M$25M

    PHINEX - CENEXI's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    PHINEX - CENEXI's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.